FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106981111> ?p ?o ?g. }

• W2106981111 endingPage "e15588" @default.
• W2106981111 startingPage "e15588" @default.
• W2106981111 abstract "Sorafenib monotherapy in patients with metastatic melanoma was explored in this multi-institutional phase II study. In correlative studies the impact of sorafenib on cyclin D1 and Ki67 was assessed.Thirty-six patients treatment-naïve advanced melanoma patients received sorafenib 400 mg p.o. twice daily continuously. Tumor BRAF(V600E) mutational status was determined by routine DNA sequencing and mutation-specific PCR (MSPCR). Immunohistochemistry (IHC) staining for cyclin D1 and Ki67 was performed on available pre- and post treatment tumor samples. The main toxicities included diarrhea, alopecia, rash, mucositis, nausea, hand-foot syndrome, and intestinal perforation. One patient had a RECIST partial response (PR) lasting 175 days. Three patients experienced stable disease (SD) with a mean duration of 37 weeks. Routine BRAF(V600E) sequencing yielded 27 wild-type (wt) and 6 mutant tumors, whereas MSPCR identified 12 wt and 18 mutant tumors. No correlation was seen between BRAF(V600E) mutational status and clinical activity. No significant changes in expression of cyclin D1 or Ki67 with sorafenib treatment were demonstrable in the 15 patients with pre-and post-treatment tumor samples.Sorafenib monotherapy has limited activity in advanced melanoma patients. BRAF(V600E) mutational status of the tumor was not associated with clinical activity and no significant effect of sorafenib on cyclin D1 or Ki67 was seen, suggesting that sorafenib is not an effective BRAF inhibitor or that additional signaling pathways are equally important in the patients who benefit from sorafenib.Clinical Trials.gov NCT00119249." @default.
• W2106981111 created "2016-06-24" @default.
• W2106981111 creator A5002545881 @default.
• W2106981111 creator A5006002735 @default.
• W2106981111 creator A5012143202 @default.
• W2106981111 creator A5021752290 @default.
• W2106981111 creator A5022698513 @default.
• W2106981111 creator A5024592292 @default.
• W2106981111 creator A5027165899 @default.
• W2106981111 creator A5027826184 @default.
• W2106981111 creator A5041066193 @default.
• W2106981111 creator A5051174968 @default.
• W2106981111 creator A5056507476 @default.
• W2106981111 creator A5065486178 @default.
• W2106981111 creator A5066888960 @default.
• W2106981111 creator A5080635562 @default.
• W2106981111 date "2010-12-29" @default.
• W2106981111 modified "2023-10-05" @default.
• W2106981111 title "A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates" @default.
• W2106981111 cites W1879616740 @default.
• W2106981111 cites W1917632054 @default.
• W2106981111 cites W1967835627 @default.
• W2106981111 cites W1971837077 @default.
• W2106981111 cites W1987166169 @default.
• W2106981111 cites W1989121777 @default.
• W2106981111 cites W1994376203 @default.
• W2106981111 cites W1999966467 @default.
• W2106981111 cites W2004295816 @default.
• W2106981111 cites W2019950585 @default.
• W2106981111 cites W2029080338 @default.
• W2106981111 cites W2034048944 @default.
• W2106981111 cites W2051165598 @default.
• W2106981111 cites W2066635600 @default.
• W2106981111 cites W2073363047 @default.
• W2106981111 cites W2073548269 @default.
• W2106981111 cites W2083776086 @default.
• W2106981111 cites W2103027517 @default.
• W2106981111 cites W2106543129 @default.
• W2106981111 cites W2109513968 @default.
• W2106981111 cites W2131819768 @default.
• W2106981111 cites W2137705897 @default.
• W2106981111 cites W2137723371 @default.
• W2106981111 cites W2139248078 @default.
• W2106981111 cites W2139684524 @default.
• W2106981111 cites W2140765540 @default.
• W2106981111 cites W2140777372 @default.
• W2106981111 cites W2144916887 @default.
• W2106981111 cites W2154196978 @default.
• W2106981111 cites W2154493372 @default.
• W2106981111 cites W2156266404 @default.
• W2106981111 cites W2163188200 @default.
• W2106981111 cites W2167039800 @default.
• W2106981111 doi "https://doi.org/10.1371/journal.pone.0015588" @default.
• W2106981111 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3012061" @default.
• W2106981111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21206909" @default.
• W2106981111 hasPublicationYear "2010" @default.
• W2106981111 type Work @default.
• W2106981111 sameAs 2106981111 @default.
• W2106981111 citedByCount "88" @default.
• W2106981111 countsByYear W21069811112012 @default.
• W2106981111 countsByYear W21069811112013 @default.
• W2106981111 countsByYear W21069811112014 @default.
• W2106981111 countsByYear W21069811112015 @default.
• W2106981111 countsByYear W21069811112016 @default.
• W2106981111 countsByYear W21069811112017 @default.
• W2106981111 countsByYear W21069811112018 @default.
• W2106981111 countsByYear W21069811112019 @default.
• W2106981111 countsByYear W21069811112020 @default.
• W2106981111 countsByYear W21069811112021 @default.
• W2106981111 crossrefType "journal-article" @default.
• W2106981111 hasAuthorship W2106981111A5002545881 @default.
• W2106981111 hasAuthorship W2106981111A5006002735 @default.
• W2106981111 hasAuthorship W2106981111A5012143202 @default.
• W2106981111 hasAuthorship W2106981111A5021752290 @default.
• W2106981111 hasAuthorship W2106981111A5022698513 @default.
• W2106981111 hasAuthorship W2106981111A5024592292 @default.
• W2106981111 hasAuthorship W2106981111A5027165899 @default.
• W2106981111 hasAuthorship W2106981111A5027826184 @default.
• W2106981111 hasAuthorship W2106981111A5041066193 @default.
• W2106981111 hasAuthorship W2106981111A5051174968 @default.
• W2106981111 hasAuthorship W2106981111A5056507476 @default.
• W2106981111 hasAuthorship W2106981111A5065486178 @default.
• W2106981111 hasAuthorship W2106981111A5066888960 @default.
• W2106981111 hasAuthorship W2106981111A5080635562 @default.
• W2106981111 hasBestOaLocation W21069811111 @default.
• W2106981111 hasConcept C121608353 @default.
• W2106981111 hasConcept C126322002 @default.
• W2106981111 hasConcept C143998085 @default.
• W2106981111 hasConcept C199835354 @default.
• W2106981111 hasConcept C2777658100 @default.
• W2106981111 hasConcept C2778019345 @default.
• W2106981111 hasConcept C2778496288 @default.
• W2106981111 hasConcept C2778695046 @default.
• W2106981111 hasConcept C2779984678 @default.
• W2106981111 hasConcept C29537977 @default.
• W2106981111 hasConcept C31760486 @default.
• W2106981111 hasConcept C502942594 @default.
• W2106981111 hasConcept C509974204 @default.

• next